{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.508","meta":{"versionId":"12","lastUpdated":"2019-12-04T01:00:20.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Flow Cytometry Studies Performed</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://www.ama-assn.org/go/cpt</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>1012415</td>\n              <td>Flow cytometry, interpretation</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3170F</td>\n              <td>Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>88184</td>\n              <td>Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>88185</td>\n              <td>Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>88187</td>\n              <td>Flow cytometry, interpretation; 2 to 8 markers</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>88189</td>\n              <td>Flow cytometry, interpretation; 16 or more markers</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.508","version":"20191204","name":"Flow Cytometry Studies Performed","status":"active","date":"2019-12-04T01:00:20-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"1012415","display":"Flow cytometry, interpretation"},{"code":"3170F","display":"Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"},{"code":"88184","display":"Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker"},{"code":"88185","display":"Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)"},{"code":"88187","display":"Flow cytometry, interpretation; 2 to 8 markers"},{"code":"88189","display":"Flow cytometry, interpretation; 16 or more markers"}]}]}}